The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Provides the mathematical model described by "Serostatus Testing & Dengue Vaccine Cost-Benefit Thresholds" in <doi:10.1098/rsif.2019.0234>. Using the functions in the package, that analysis can be repeated using sample life histories, either synthesized from local seroprevalence data using other functions in this package (as in the manuscript) or from some other source. The package provides a vignette which walks through the analysis in the publication, as well as a function to generate a project skeleton for such an analysis.
Version: | 0.1.2 |
Depends: | R (≥ 3.5) |
Suggests: | data.table, testthat, usethis, devtools, roxygen2, jsonlite, ggplot2, cowplot, directlabels, rmarkdown, knitr |
Published: | 2019-12-01 |
DOI: | 10.32614/CRAN.package.denvax |
Author: | Carl A. B. Pearson [aut, cre], Kaja M. Abbas [aut], Samuel Clifford [aut], Stefan Flasche [aut], Thomas J. Hladish [aut] |
Maintainer: | Carl A. B. Pearson <carl.pearson at lshtm.ac.uk> |
BugReports: | https://gitlab.com/cabp_LSHTM/denvax/issues |
License: | MIT + file LICENSE |
URL: | https://gitlab.com/cabp_LSHTM/denvax |
NeedsCompilation: | no |
CRAN checks: | denvax results |
Reference manual: | denvax.pdf |
Vignettes: |
published-analysis |
Package source: | denvax_0.1.2.tar.gz |
Windows binaries: | r-devel: denvax_0.1.2.zip, r-release: denvax_0.1.2.zip, r-oldrel: denvax_0.1.2.zip |
macOS binaries: | r-release (arm64): denvax_0.1.2.tgz, r-oldrel (arm64): denvax_0.1.2.tgz, r-release (x86_64): denvax_0.1.2.tgz, r-oldrel (x86_64): denvax_0.1.2.tgz |
Old sources: | denvax archive |
Please use the canonical form https://CRAN.R-project.org/package=denvax to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.